Literature DB >> 26500143

Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation.

S S Kenderian1, F G Rosado2, D B Sykes3, J D Hoyer2, M Q Lacy1.   

Abstract

Mesh：

Year:  2015        PMID： 26500143     DOI： 10.1038/leu.2015.298

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Schnitzler syndrome: an under-diagnosed clinical entity.

Authors:  Tania Jain; Chetan P Offord; Robert A Kyle; David Dingli
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

2.  Perirenal fluid collections and monoclonal gammopathy.

Authors:  Denis Viglietti; Jean-Michel Sverzut; Marie-Noëlle Peraldi
Journal:  Nephrol Dial Transplant       Date:  2011-08-02       Impact factor: 5.992

3.  The TEMPI syndrome--a novel multisystem disease.

Authors:  David B Sykes; Wilfried Schroyens; Casey O'Connell
Journal:  N Engl J Med       Date:  2011-08-04       Impact factor: 91.245

4.  Complete and partial responses of the TEMPI syndrome to bortezomib.

Authors:  Wilfried Schroyens; Casey O'Connell; David B Sykes
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

5.  Subcutaneous bortezomib for treatment of TEMPI syndrome.

Authors:  Sina Jasim; Gibran Mahmud; Bahar Bastani; Mark Fesler
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-07-15

6.  Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.

Authors:  Anita D'Souza; Martha Lacy; Morie Gertz; Shaji Kumar; Francis Buadi; Suzanne Hayman; David Dingli; Steven Zeldenrust; Robert Kyle; Stephen Ansell; David Inwards; Patrick Johnston; Ivana Micallef; Luis Porrata; Mark Litzow; Dennis Gastineau; William Hogan; Angela Dispenzieri
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

7.  Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.

Authors:  Martha Q Lacy; William J Hogan; Morie A Gertz; Angela Dispenzieri; S Vincent Rajkumar; Suzanne Hayman; Shaji Kumar; Mark R Litzow; Arnold L Schroeter
Journal:  Arch Dermatol       Date:  2005-10

Review 8.  Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

Authors:  A Dispenzieri; K Seenithamby; M Q Lacy; S K Kumar; F K Buadi; S R Hayman; D Dingli; M R Litzow; D A Gastineau; D J Inwards; I N Micallef; S M Ansell; P B Johnston; L F Porrata; M M Patnaik; W J Hogan; M A A Gertz
Journal:  Bone Marrow Transplant       Date:  2013-04-22       Impact factor: 5.483

9.  Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist.

Authors:  Flavia G Rosado; Jennifer L Oliveira; Aliya R Sohani; Wilfried Schroyens; David B Sykes; Saad S Kenderian; Martha Q Lacy; Robert A Kyle; James D Hoyer
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

10.  Bortezomib to treat the TEMPI syndrome.

Authors:  Mary Kwok; Neha Korde; Ola Landgren
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245
View more
  6 in total

Review 1.  TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis.

Authors:  Jian Xu; Wenqi Liu; Fengjuan Fan; Bo Zhang; Fei Zhao; Yu Hu; Chunyan Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

2.  Polycythaemia: an unusual presentation of multiple myeloma.

Authors:  Elaine J Hutchison; Josephine A Taverna; Qi Yu; Andrew M Yeager
Journal:  BMJ Case Rep       Date:  2016-09-20

3.  Diffuse telangiectasia: A clue to the TEMPI syndrome.

Authors:  Yeping Ruan; Xiaoqing Zhao; Meng Pan
Journal:  JAAD Case Rep       Date:  2021-02-27

4.  Ocular involvement in TEMPI syndrome.

Authors:  Jo-Hsuan Wu; Narine Viruni; Justin Chun; Satish Shanbhag; T Y Alvin Liu
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

Review 5.  Cutaneous manifestations of monoclonal gammopathy.

Authors:  Jean-Sebastien Claveau; David A Wetter; Shaji Kumar
Journal:  Blood Cancer J       Date:  2022-04-11       Impact factor: 11.037

6.  Case Report: TEMPI syndrome: Report of three cases and treatment follow-up.

Authors:  Zhuo-Fan Xu; Jing Ruan; Long Chang; Sijin Wu; Jinkai Lin; Wei Wang; XinXin Cao; Lu Zhang; Jian Li; Daobin Zhou; Wei Zhang
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.